Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Joly

Showing results (191-200 of 227) with videos related to

Pageof 23
Sort By:
Journal of the American Academy of Dermatology|July 22, 2014
Syringotropic mycosis fungoides: clinical and histologic features, response to treatment, and outcome in 19 patientsAdèle de Masson, Maxime Battistella, Marie-Dominique Vignon-Pennamen, et al.
JID Innovations : Skin Science From Molecules to Population Health|February 5, 2025
Meeting Report on "10th Anniversary Symposium on Inflammatory Skin Disease"Shirin Emtenani, John F Baines, Katja Bieber, et al.
The Journal of Investigative Dermatology|March 30, 2018
A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg TypeMarie Beylot-Barry, Diane Mermin, Aline Maillard, et al.
The British Journal of Dermatology|May 22, 2025
Evaluation of the efficacy and safety of dapsone alone or associated with topical corticosteroids for pemphigus foliaceus: a retrospective multicenter studySofia Tzoumpa, Gérôme Bohelay, Saskia Ingen-Housz-Oro, et al.
Journal of the American Academy of Dermatology|July 31, 2012
Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a familyEve Maubec, Valérie Chaudru, Hamida Mohamdi, et al.
JID Innovations : Skin Science From Molecules to Population Health|July 21, 2022
How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International SurveyMarine Guignant, Billal Tedbirt, Dedee F Murrell, et al.
JAMA Dermatology|June 1, 2017
Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 CasesValentine Heidelberger, Saskia Ingen-Housz-Oro, Alicia Marquet, et al.
Journal of the American Academy of Dermatology|October 3, 2020
Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: A multicenter, double-blind, randomized controlled studyPascal Joly, Ines Tejedor, Florence Tetart, et al.
The British Journal of Dermatology|May 11, 2026
Incidence and Mortality of Mucous Membrane Pemphigoid in FranceAlexis Lefebvre, André Gillibert, Emmanuelle Tancrede-Bohin, et al.
The Journal of Investigative Dermatology|January 30, 2009
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized studyPascal Joly, Jean-Claude Roujeau, Jacques Benichou, et al.
Pageof 23

Showing results (191-200 of 227) with videos related to

Sort By:
Pageof 23
Journal of the American Academy of Dermatology|July 22, 2014
Syringotropic mycosis fungoides: clinical and histologic features, response to treatment, and outcome in 19 patientsAdèle de Masson, Maxime Battistella, Marie-Dominique Vignon-Pennamen, et al.
JID Innovations : Skin Science From Molecules to Population Health|February 5, 2025
Meeting Report on "10th Anniversary Symposium on Inflammatory Skin Disease"Shirin Emtenani, John F Baines, Katja Bieber, et al.
The Journal of Investigative Dermatology|March 30, 2018
A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg TypeMarie Beylot-Barry, Diane Mermin, Aline Maillard, et al.
The British Journal of Dermatology|May 22, 2025
Evaluation of the efficacy and safety of dapsone alone or associated with topical corticosteroids for pemphigus foliaceus: a retrospective multicenter studySofia Tzoumpa, Gérôme Bohelay, Saskia Ingen-Housz-Oro, et al.
Journal of the American Academy of Dermatology|July 31, 2012
Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a familyEve Maubec, Valérie Chaudru, Hamida Mohamdi, et al.
JID Innovations : Skin Science From Molecules to Population Health|July 21, 2022
How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International SurveyMarine Guignant, Billal Tedbirt, Dedee F Murrell, et al.
JAMA Dermatology|June 1, 2017
Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 CasesValentine Heidelberger, Saskia Ingen-Housz-Oro, Alicia Marquet, et al.
Journal of the American Academy of Dermatology|October 3, 2020
Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: A multicenter, double-blind, randomized controlled studyPascal Joly, Ines Tejedor, Florence Tetart, et al.
The British Journal of Dermatology|May 11, 2026
Incidence and Mortality of Mucous Membrane Pemphigoid in FranceAlexis Lefebvre, André Gillibert, Emmanuelle Tancrede-Bohin, et al.
The Journal of Investigative Dermatology|January 30, 2009
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized studyPascal Joly, Jean-Claude Roujeau, Jacques Benichou, et al.
Pageof 23